Novel approaches to the management of bone metastases in patients with breast cancerHORTOBAGYI, Gabriel N.Seminars in oncology. 2002, Vol 29, Num 3, pp 134-144, issn 0093-7754, SUP11Article

Opportunities and challenges in the development of targeted therapiesHORTOBAGYI, Gabriel N.Seminars in oncology. 2004, Vol 31, Num 1, pp 21-27, issn 0093-7754, 7 p., SUP3Article

Novel approaches to the management of bone metastasesHORTOBAGYI, Gabriel N.Seminars in oncology. 2003, Vol 30, Num 5, pp 161-166, issn 0093-7754, 6 p., SUP16Conference Paper

Overview of treatment results with trastuzumab (herceptin) in metastatic breast cancerHORTOBAGYI, Gabriel N.Seminars in oncology. 2001, Vol 28, Num 6, pp 43-47, issn 0093-7754, SUP18Conference Paper

Progress and Controversies in Targeted Therapies of Breast CancerHORTOBAGYI, Gabriel N.Seminars in oncology. 2003, Vol 30, Num 5, issn 0093-7754, 187 p., SUP16Conference Proceedings

Adjuvant systemic therapy for early breast cancer: progress and controversiesHORTOBAGYI, Gabriel N.Clinical cancer research. 2001, Vol 7, Num 7, pp 1839-1842, issn 1078-0432Article

Targeted therapies in the treatment of breast cancerHORTOBAGYI, Gabriel N.Seminars in oncology. 2002, Vol 29, Num 3, issn 0093-7754, 170 p., SUP11Serial Issue

Targeting HER2: Recent developments and future directions for breast cancer patientsHORTOBAGYI, Gabriel N.Seminars in oncology. 2001, Vol 28, Num 6, issn 0093-7754, 61 p., SUP18Conference Proceedings

Targeted Therapies in the Treatment of Breast CancerHORTOBAGYI, Gabriel N.Seminars in oncology. 2001, Vol 28, Num 5, issn 0093-7754, 155 p., SUP16Conference Proceedings

M.D. Anderson Conference on Trastuzmab (Herceptin)HORTOBAGYI, Gabriel N.Seminars in oncology. 1999, Vol 26, Num 4, issn 0093-7754, 132 p., SUP12Conference Proceedings

Future directions in the endocrine therapy of breast cancerHORTOBAGYI, Gabriel N.Breast cancer research and treatment. 2003, Vol 80, pp S37-S39, issn 0167-6806, SUP1Conference Paper

The insulin-like growth factor system as a treatment target in breast cancerYEE, Douglas.Seminars in oncology. 2002, Vol 29, Num 3, pp 86-95, issn 0093-7754, SUP11Article

Anti-HER2 monoclonal antibody: recent developments and future directions for the treatment of breast cancerHORTOBAGYI, Gabriel N; KHAYAT, David.Seminars in oncology. 2000, Vol 27, Num 5, issn 0093-7754, 56 p., SUP9Conference Proceedings

Sequential paclitaxel reduces recurrence and mortality in women with early breast cancerBUZDAR, Aman U; HORTOBAGYI, Gabriel N.Cancer treatment reviews. 2003, Vol 29, Num 5, pp 449-452, issn 0305-7372, 4 p.Article

Docetaxel in the treatment of non-small cell lung, ovarian, and breast cancersHORTOBAGYI, Gabriel N; KRIS, Mark G.Seminars in oncology. 2002, Vol 29, Num 3, issn 0093-7754, 35 p., SUP12Serial Issue

Gemcitabine and targeted therapy in metastatic breast cancerGUANGZHI QU; PEREZ, Edith A.Seminars in oncology. 2002, Vol 29, Num 3, pp 44-52, issn 0093-7754, SUP11Article

Recent developments and future directions with HER-2 in breast cancer and other tumor typesHORTOBAGYI, Gabriel N.Seminars in oncology. 2000, Vol 27, Num 6, issn 0093-7754, 109 p., SUP11Conference Proceedings

Recent progress in the clinical development of docetaxel (Taxotere)HORTOBAGYI, G. N.Seminars in oncology. 1999, Vol 26, Num 3, pp 32-36, issn 0093-7754, SUP9Article

Doxorubicin/taxane combinations : Cardiac toxicity and pharmacokineticsSPARANO, J. A.Seminars in oncology. 1999, Vol 26, Num 3, pp 14-19, issn 0093-7754, SUP9Article

Emerging role of docetaxel (Taxotere) in the adjuvant therapy of breast cancerRAVDIN, P. M.Seminars in oncology. 1999, Vol 26, Num 3, pp 20-23, issn 0093-7754, SUP9Article

Trastuzumab and cardiac dysfunction: Update on preclinical studiesKLEIN, Pamela M; DYBDAL, Noël.Seminars in oncology. 2003, Vol 30, Num 5, pp 49-53, issn 0093-7754, 5 p., SUP16Conference Paper

Vascular endothelial growth factor in breast cancer: Biologic and therapeutic aspectsSLEDGE, George W.Seminars in oncology. 2002, Vol 29, Num 3, pp 104-110, issn 0093-7754, SUP11Article

Recent advances in aromatase inhibitor therapy for breast cancerASSIKIS, Vasily J; BUZDAR, Aman.Seminars in oncology. 2002, Vol 29, Num 3, pp 120-128, issn 0093-7754, SUP11Article

The use of HER2 testing in the management of breast cancerRAVDIN, Peter.Seminars in oncology. 2000, Vol 27, Num 5, pp 33-42, issn 0093-7754, SUP9Conference Paper

Current management of metastatic breast cancerPEREZ, E. A.Seminars in oncology. 1999, Vol 26, Num 4, pp 1-10, issn 0093-7754, SUP12Conference Paper